Eli Lilly Corp. diskutieren
Eli Lilly Corp.
WKN: 858560 / Symbol: LLY / Name: Eli Lilly / Aktie / Pharmazeutika / Large Cap /
815,20 €
2,45 %
Eli Lilly and Company (NYSE: LLY) had its "buy" rating re-affirmed by analysts at Truist Financial Co.. They now have a $1,000.00 price target on the stock, up previously from $892.00.
Ratings data for LLY provided by MarketBeat
Eli Lilly and Company (NYSE: LLY) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $885.00 price target on the stock.
Ratings data for LLY provided by MarketBeat
Eli Lilly and Company (NYSE: LLY) had its "outperform" rating re-affirmed by analysts at BMO Capital Markets. They now have a $1,001.00 price target on the stock.
Ratings data for LLY provided by MarketBeat
Eli Lilly and Company (NYSE: LLY) had its "overweight" rating re-affirmed by analysts at Morgan Stanley. They now have a $1,023.00 price target on the stock.
Ratings data for LLY provided by MarketBeat
Eli Lilly and Company (NYSE: LLY) had its price target raised by analysts at Barclays PLC from $913.00 to $1,025.00. They now have an "overweight" rating on the stock.
Ratings data for LLY provided by MarketBeat
Eli Lilly and Company (NYSE: LLY) had its price target raised by analysts at JPMorgan Chase & Co. from $900.00 to $1,000.00. They now have an "overweight" rating on the stock.
Ratings data for LLY provided by MarketBeat
Eli Lilly and Company (NYSE: LLY) had its price target raised by analysts at Berenberg Bank from $850.00 to $1,000.00. They now have a "buy" rating on the stock.
Ratings data for LLY provided by MarketBeat
Neueste Beiträge
Glj_Research in Tesla Inc diskutieren